UPDATE: 10:30 p.m. – A new state of the art manufacturing building was built back in 2006, however it needed to get FDA approval and just this year in August, it did.
A company spokesperson tells 6 News that employees at Emergent BioSolutions were aware the new facility would be less labor intensive, meaning fewer employees are needed to operate it; so this didn’t just come out of nowhere..
A total of 91 people will lose their jobs, which accounts for 24 percent of the workforce.
It affects those in the manufacturing, facilities, and engineering departments. In order to meet the new staffing requirements, Emergent offered twice the severance pay they normally give out.
A company spokesperson says that’s because of the important role all of these employees have played in the company.
Of the 91 people, 28 of them left voluntarily, after accepting the severance package.
In addition, a private contractor has been brought in to help all those affected by these cuts, find new jobs.
It’s a move that company officials say isn’t easy, but they are doing everything they can to make it a smooth transition.
“They’re all really good people, they’re hard workers and this isn’t easy for any of us, I mean there’s no doubt about it,” Mike Alley, PR Director, Emergent BioSolutions said. “It’s a state of the industry building and the bottom line is, that we have people here where we don’t have work for them to do.”
There will be just under 300 employees who will work at this new facility.
Emergent BioSolutions will continue its mission, which is to protect and enhance 50 million lives by 2025.
LANSING, Mich (WLNS) – 6 News has confirmed that Emergent BioSolutions is cutting 91 jobs in Lansing.
Mark Alley, the Public Relations Director for Emergent BioSolutions, tells 6 News that the people were told today they will be losing their jobs.
Alley says the staff reductions are related to the company has a new production facility and fewer people are needed for manufacturing product.
6 News is told that the employees knew that the new facility would result in job cuts and Emergent had been very transparent through the entire process of bring the facility online.
Emergent BioSolutions makes BioThrax, an antidote to anthrax. It is the only anthrax vaccine licensed by the U.S. Food and Drug Administration.
To meet the new staffing requirements Emergent offered employees twice the severance pay normally paid out. Alley said 28 people left voluntarily when they received the offer and 63 others were let go.
The staff reduction accounts for 24 percent of the workforce and reaches across the manufacturing, facilities and engineering departments.
When the cuts are completed there will be 286 employees working at the new facility.
Emergent BioSolutions was founded on September 5, 1998, under the name BioPort. It is a multinational company with BioThrax produced at the former State of Michigan Health Department facility on N. Martin Luther King Boulevard, which the state sold to Emergent BioSolutions with the rights to produce the anthrax vaccine.
Emergent BioSolutions has gone on the record as saying its mission is to protect and enhance 50 million lives by 2025.